Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

Ettinger, B. (1999) · JAMA · doi:10.1001/jama.282.7.637 · Cited by 3,366

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Harris, S. T. (1999) · JAMA · doi:10.1001/jama.282.14.1344 · Cited by 2,475

Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>

Cummings, S. R. (1998) · JAMA · doi:10.1001/jama.280.24.2077 · Cited by 2,277

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J. A., Downs, R. W., Dequeker, J., Favus, M. J., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,276

Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

Reginster, J.-Y., Minne, H. W., Sorensen, O. H., Hooper, M., Roux, C., Brandi, M. L., Lund, B., Ethgen, D., Pack, S., Roumagnac, I., et al. (2000) · Osteoporosis International · doi:10.1007/s001980050010 · Cited by 1,580

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study

Chesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., et al. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00490-3 · Cited by 1,122

Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study

Garnero, P., Hausherr, E., Chapuy, M. C., Marcelli, C., Grandjean, H., Müller, C., Cormier, C., Bréart, G., Meunier, P. J., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 984

Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P. D., Woodson, G. C., Yanover, M., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 947

Osteoporosis and Strength Training

Going, S. B., & Laudermilk, M. (2009) · American Journal of Lifestyle Medicine · doi:10.1177/1559827609334979 · Cited by 19

The Effects of Antifracture Therapies on the Components of Bone Strength: Assessment of Fracture Risk Today and in the Future

Davison, K. S., Siminoski, K. G., Adachi, J. D., Hanley, D. A., Goltzman, D., Hodsman, A. B., Josse, R. G., Kaiser, S., Olszynski, W. P., Παπαϊωάννου, Α., et al. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.04.001 · Cited by 17

Fractal Dimension Analysis of Mandibular Trabecular Bone in Patients Receiving Antiresorptive Therapy for Osteoporosis and Oncologic Conditions

Sevimay, M. A., Gürsu, M., Çege, M. A., Çankal, D. A., Akarslan, Z. Z., & Çeti̇ner, S. (2025) · Diagnostics · doi:10.3390/diagnostics15060748 · Cited by 17

Loss of longitudinal superiority marks the microarchitecture deterioration of osteoporotic cancellous bones

Li, Z., Liu, P., Yuan, Y., Liang, X., Lei, J., Zhu, X., Zhang, Z., & Cai, L. (2021) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-021-01491-z · Cited by 17

Use of Fracture Risk Assessment Tool in clinical practice and Fracture Risk Assessment Tool future directions

Zerikly, R., & Demetriou, E. W. (2024) · Women s Health · doi:10.1177/17455057241231387 · Cited by 17

Parametric response mapping of CT images provides early detection of local bone loss in a rat model of osteoporosis

Hoff, B. A., Kozloff, K. M., Boes, J. L., Brisset, J., Galbán, S., Poznak, C. H. V., Jacobson, J. A., Johnson, T. D., Meyer, C. R., Rehemtulla, A., et al. (2012) · Bone · doi:10.1016/j.bone.2012.04.005 · Cited by 17

Bone Mineral Density Response from Teriparatide in Patients with Osteoporosis

Kim, S.-Y., Zhang, M., & Bockman, R. S. (2017) · HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery · doi:10.1007/s11420-016-9537-1 · Cited by 17

Skeletal effects of short-term exposure to dexamethasone and response to risedronate treatment studied in vivo in rabbits by magnetic resonance micro-imaging and spectroscopy

Takahashi, M., Saha, P. K., & Wehrli, F. W. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0712-1 · Cited by 17

A Simulation Model at Trabecular Level to Predict Effects of Antiresorptive Treatment after Menopause

van der Linden, J. C., Verhaar, J. A. N., Pols, H. A. P., & Weinans, H. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-2151-x · Cited by 18

Skeletal Heterogeneity and the Purposes of Bone Remodeling: Implications for the Understanding of Osteoporosis

PARFITT, A. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50006-8 · Cited by 18

Bisphosphonates for Breast Cancer: Questions Answered, Questions Remaining

Layman, R. M., Olson, K. B., & Poznak, C. H. V. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.03.004 · Cited by 17

Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis

Kreck, S., Klaus, J., Leidl, R., von Tirpitz, C., Konnopka, A., Matschinger, H., & König, H. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826040-00004 · Cited by 17

Treatment of Osteoporosis: All the Questions We Still Cannot Answer

Laroche, M. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.03.048 · Cited by 17

The Role of Exercise on Fracture Reduction and Bone Strengthening

KEMMLER, W. K., & von Stengel, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814593-7.00020-7 · Cited by 16

Operationalizing Treat-to-Target for Osteoporosis

Lewiecki, E. M. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.970 · Cited by 17

Improved prediction of rat cortical bone mechanical behavior using composite beam theory to integrate tissue level properties

Kim, G., Boskey, A. L., Baker, S. P., & van der Meulen, M. C. H. (2012) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2012.08.042 · Cited by 16

Goal-directed therapy in osteoporosis

McCloskey, E. V., & Leslie, W. D. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1859 · Cited by 16

Novel imaging modalities for the comparison of bone microarchitecture among HIV+ patients with and without fractures: a pilot study

Tan, D. H. S., Raboud, J., Szadkowski, L., Szabo, E., Hu, H., Wong, Q., Cheung, A. M., & Walmsley, S. L. (2016) · HIV Clinical Trials · doi:10.1080/15284336.2016.1266074 · Cited by 16

Baseline serum estradiol and fracture reduction during treatment with hormone therapy: The Women's Health Initiative randomized trial

Cauley, J. A., LaCroix, A. Z., Robbins, J. A., Larson, J. C., Wallace, R. B., Wactawski‐Wende, J., Chen, Z., Bauer, D. C., Cummings, S. R., & Jackson, R. D. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0953-7 · Cited by 16

Bone strength and surrogate markers: The first, second, and third fiddle

Miller, P. D. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1673 · Cited by 16

Österreichischer Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose – Update 2009

Dimai, H. P., Pietschmann, P., Resch, H., Preisinger, E., Fahrleitner‐Pammer, A., Dobnig, H., & Klaushofer, K. (2009) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-009-0656-x · Cited by 16

Non-invasive measurements of bone strength: promise and peril.

Bouxsein, M. (2004) · PubMed · Cited by 16

MANAGEMENT OF PRIMARY OSTEOPOROSIS

Body, J. J. (2002) · Acta Clinica Belgica · doi:10.1179/acb.2002.054 · Cited by 16

Treatment responses with once-weekly teriparatide therapy for osteoporosis

Shiraki, M., Ueda, S., Sugimoto, T., Kuroda, T., & Nakamura, T. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3640-5 · Cited by 15

Markers of Bone and Cartilage Turnover

Woitge, H. W., & Seibel, M. J. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-106438 · Cited by 15

Raman spectroscopy as a predictive tool for monitoring osteoporosis therapy in a rat model of postmenopausal osteoporosis

Beattie, J. R., Sophocleous, A., Caraher, M. C., O'Driscoll, O. M., Cummins, N. M., Bell, S. E. J., Towler, M. R., Yazdi, A. R., Ralston, S. H., & Idris, A. I. (2019) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-019-6226-x · Cited by 15

Application of a Neural Network Classifier to Radiofrequency-Based Osteopenia/Osteoporosis Screening

Adams, J., Zhang, Z., Noetscher, G. M., Nazarian, A., & Makarov, S. N. (2021) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2021.3108575 · Cited by 15

Effects of the combination treatment of raloxifene and alendronate on the biomechanical properties of vertebral bone

Diab, T., Wang, J., Reinwald, S., Guldberg, R. E., & Burr, D. B. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.197 · Cited by 15

A poisson process model for hip fracture risk

Schechner, Z., Luo, G., Kaufman, J. J., & Siffert, R. S. (2010) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-010-0638-6 · Cited by 15

Evaluation of the anti-osteoporotic effect of Ginkgo biloba L. in Wistar rats with glucocorticoid-induced-osteoporosis by bone densitometry using dual-energy x-ray absorptiometry (DEXA) and mechanical testing

Lucinda, L. M. F., Aarestrup, B. J. V., Reboredo, M. M., PAINS, T. D. A., CHAVES, R. Z., REIS, J. E. P., Louzada, M. J. Q., & Guerra, M. O. (2017) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201720160479 · Cited by 16

Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene

Reginster, J., Ferrari, S., & Hadji, P. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.890927 · Cited by 15

Biomechanics of Vertebral Bone

Keaveny, T. M., & Buckley, J. M. (2006) · Elsevier eBooks · doi:10.1016/b978-012369390-7/50005-8 · Cited by 15

Bisphosphonates: Pharmacology and Use in the Treatment of Osteoporosis

Miller, P. D. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50076-8 · Cited by 15

Combination therapy of raloxifene and alendronate for treatment of osteoporosis in elderly women

Um, M. J., Cho, E. A., & Jung, H. (2017) · Journal of Menopausal Medicine · doi:10.6118/jmm.2017.23.1.56 · Cited by 14

Health Professional's Guide to Rehabilitation of the Patient with Osteoporosis

Bouxsein, M. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1467-3 · Cited by 14

Osteoporosis treatment: why ibandronic acid?

Rossini, M., Orsolini, G., Adami, S., Kunnathully, V., & Gatti, D. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.795949 · Cited by 13

Biologicals in Osteoporosis: Teriparatide and Parathyroid Hormone in Women and Men

Devogelaer, J., Boutsen, Y., & Manicourt, D. H. (2010) · Current Osteoporosis Reports · doi:10.1007/s11914-010-0024-1 · Cited by 13

Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study

Pedersen, S. B., Rand, M. S., Haddock, B., Arup, S., Smith, C., Jensen, J. B., Schwarz, P., Hovind, P. H., Oturai, P., Jensen, L. T., et al. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06457-0 · Cited by 13

Rationale for Bone Densitometry in Childhood and Adolescence

Sawyer, A., & Bachrach, L. K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-211-3_1 · Cited by 13

Relationship Among MRTA, DXA, and QUS

Djokoto, C., TOMLINSON, G. A., Waldman, S. D., Grynpas, M. D., & Cheung, A. M. (2004) · Journal of Clinical Densitometry · doi:10.1385/jcd:7:4:448 · Cited by 13

Patient Assessment in the Diagnosis, Prevention, and Treatment of Osteoporosis

Lata, P. F., & Elliott, M. E. (2007) · Nutrition in Clinical Practice · doi:10.1177/0115426507022003261 · Cited by 13

Effect of risedronate on hip structural geometry: A 1-year, double-blind trial in chemotherapy-induced postmenopausal women

Londen, G. J. V., Perera, S., Vujevich, K. T., Sereika, S. M., Bhattacharya, R. K., & Greenspan, S. L. (2008) · Bone · doi:10.1016/j.bone.2008.03.027 · Cited by 13

Parathyroidectomy in the elderly is beneficial and safe with similar improvements in postoperative bone mineral density

Hangge, P. T., Norain, A., Butterfield, R. J., Wasif, N., Cronin, P. A., & Stucky, C. (2022) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2022.04.031 · Cited by 12

Lebanese Guidelines for Osteoporosis Assessment and Treatment

Fuleihan, G. E., Baddoura, R., Awada, H., Okais, J., Rizk, P., & McClung, M. R. (2005) · Journal of Clinical Densitometry · doi:10.1385/jcd:8:2:148 · Cited by 12

Once-monthly oral ibandronate in postmenopausal osteoporosis: Translation and updated review

Rossini, M., Viapiana, O., Gatti, D., & Adami, S. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.07.018 · Cited by 12

Romosozumab Treatment Converts Trabecular Rods into Trabecular Plates in Male Cynomolgus Monkeys

Matheny, J. B., Torres, A. M., Ominsky, M. S., & Hernandez, C. J. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0258-3 · Cited by 12

Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax®) for osteoporosis treatment

Unnanuntana, A., Jarusriwanna, A., & Songcharoen, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180325 · Cited by 12

Diminishing Value from Multiple Serial Bone Densitometry in Women Receiving Antiresorptive Medication for Osteoporosis

Kline, G. A., Morin, S. N., Feldman, S., Lix, L. M., & Leslie, W. D. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab211 · Cited by 12

Prediction of bone mass gain by bone turnover parameters after parathyroidectomy for primary hyperparathyroidism: neural network software statistical analysis

Leopaldi, E., Paolino, L., BEVILACQUA, M., Montecamozzo, G., Dominguez, L. J., Schipani, L. S., & Taschieri, A. M. (2006) · Surgery · doi:10.1016/j.surg.2005.11.014 · Cited by 12

Risedronate for prevention and treatment of osteoporosis in postmenopausal women

Recker, R. R., & Barger-Lux, J. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.3.465 · Cited by 12

Osteoporosis management in the new millennium

Wei, G. S., Jackson, J. L., Hatzigeorgiou, C., & Tofferi, J. K. (2003) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(03)00090-3 · Cited by 12

Does osteopenia warrant treatment?

Simon, J. A. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000156346.77014.fb · Cited by 11

Exercise for people with osteoporosis: Translating the science into clinical practice

Shipp, K. M. (2006) · Current Osteoporosis Reports · doi:10.1007/s11914-996-0020-7 · Cited by 12

Population-Based Screening for Celiac Disease

Buchman, A. L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.4.370 · Cited by 12

Screening for abdominal aortic aneurysm

Buxton, M. J. (2009) · BMJ · doi:10.1136/bmj.b2185 · Cited by 12

Hip fracture rate and osteoporosis treatment in Ontario: A population-based retrospective cohort study

Alrob, H. A., Ioannidis, G., Jaglal, S. B., Costa, A. P., Grifith, L. E., Thabane, L., Adachi, J. D., Cameron, C., Hillier, L. M., Lau, A. N., et al. (2024) · Archives of Osteoporosis · doi:10.1007/s11657-024-01402-6 · Cited by 11

Tamoxifen use correlates with increased risk of hip fractures in older women with breast cancer: A case–control study in Taiwan

Hung, S., Liao, K., Hung, H., Lin, C., Lee, W., Hung, S., & Lai, S. (2018) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13568 · Cited by 11

Review of the ultrashort echo time magnetic resonance imaging of cortical bone

Shang-Lian, B., Du, J., & Gao, S. (2013) · Acta Physica Sinica · doi:10.7498/aps.62.088701 · Cited by 11

Spine Volumetric BMD and Strength in Premenopausal Idiopathic Osteoporosis: Effect of Teriparatide Followed by Denosumab

Agarwal, S., Shane, E. J., Lang, T., Shiau, S., Kamanda‐Kosseh, M., Bucovsky, M., Lappe, J. M., Stubby, J., Recker, R. R., Hu, Y., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac232 · Cited by 12

Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients–preliminary results

Fralick, M., Bouganim, N., Kremer, R. B., Kekre, N. K., Robertson, S., Vandermeer, L., Kuchuk, I., Li, J., Murshed, M., & Clemons, M. J. (2012) · Journal of bone oncology · doi:10.1016/j.jbo.2012.10.003 · Cited by 11

Efficacy of Combined Treatment with Raloxifene and Alfacalcidol on Bone Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis

Majima, T., Komatsu, Y., Shimatsu, A., Satoh, N., Fukao, A., NINOMIYA, K., Matsumura, T., & Nakao, K. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-027 · Cited by 11

Bone turnover and inflammatory markers of bisphosphonate-related osteonecrosis of the jaw in female osteoporosis patients

Choi, S., An, C.-H., Kim, S., & Kwon, T. (2012) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2012.06.007 · Cited by 11

Lasofoxifene in osteoporosis and its place in therapy

Swan, V. J. D., Hamilton, C. J., & Jamal, S. A. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0081-y · Cited by 11

Acute Effects of Calcitonin Nasal Spray on Serum C-telopeptide of Type 1 Collagen (CTx) Levels in Elderly Osteopenic Women with Increased Bone Turnover

Srivastava, A. K., Libanati, C. R., Hohmann, O., Kriegman, A. G., & Baylink, D. J. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0036-x · Cited by 11

Bone mass measurements

Miller, P. D. (2003) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(03)00002-8 · Cited by 11

Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis

Takada, J., Miki, T., Imanishi, Y., Nakatsuka, K., Wada, H., Naka, H., Yoshizaki, T., Iba, K., Beck, T., & Yamashita, T. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0164-5 · Cited by 10

Prediction model of adjacent vertebral compression fractures after percutaneous kyphoplasty: a retrospective study

Mao, Y., Wu, W., Zhang, J., & Zhou, Y. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-064825 · Cited by 10

Biochemical Markers of Bone Turnover in Percutaneous Vertebroplasty for Osteoporotic Compression Fracture

Komemushi, A., Tanigawa, N., Kariya, S., Kojima, H., Shomura, Y., Tokuda, T., Nomura, M., Terada, J., Kamata, M., & Sawada, S. (2007) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-007-9246-8 · Cited by 10

The Importance of Absolute Bone Mineral Density in the Assessment of Antiresorptive Agents Used for the Prevention of Osteoporotic Fractures

Kuroda, T., Shiraki, M., Shiraki, Y., & Tanaka, S. (2012) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2012.02.005 · Cited by 10

Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials

Lin, T., Yan, S., Cai, X.-Z., Ying, Z., Yuan, F., & Zuo, X. (2014) · International Journal of Endocrinology · doi:10.1155/2014/796510 · Cited by 10

Microarchitecture in focus

Rizzoli, R. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1242-1 · Cited by 10

Monitoring pharmacological therapy for osteoporosis

Lewiecki, E. M. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9126-4 · Cited by 10

Microstructural, Densitometric and Metabolic Variations in Bones from Rats with Normal or Altered Skeletal States

Luu, A. N., Anez‐Bustillos, L., Aran, S., Arroyo, F. J. A., Entezari, V., Rosso, C., Snyder, B. D., & Nazarian, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082709 · Cited by 10

On the Horizon From the ORS

ARNOCZKY, S. P., Caballero, O., & Yeni, Y. N. (2010) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-201007000-00007 · Cited by 10

Modeling orthotropic elasticity, localized plasticity and fracture in trabecular bone

O'Connor, D. T., Elkhodary, K. I., Fouad, Y., Greene, M. S., Sabet, F. A., Qian, J., Zhang, Y. J., Liu, W. K., & Jasiuk, I. (2016) · Computational Mechanics · doi:10.1007/s00466-016-1301-3 · Cited by 10

Bisphosphonates: Mechanisms of Action and Role in Osteoporosis Therapy

Santora, A. C., & Sharma, A. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_14 · Cited by 12

A multiscale study of structural and compositional changes in a natural nanocomposite: Osteoporotic bone with chronic endogenous steroid excess

Xi, L., Zhang, Y., Gupta, H. S., Terrill, N. J., Wang, P., Zhao, T., & Fang, D. (2020) · Bone · doi:10.1016/j.bone.2020.115666 · Cited by 10

Combining fracture outcomes in phase 3 trials of osteoporosis: an analysis of the effects of denosumab in postmenopausal women

Kanis, J. А., Harvey, N. C., Lorentzon, M., Liu, E., Vandenput, L., McCloskey, E. V., & Johansson, H. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05699-0 · Cited by 10

A new approach to analyzing regenerated bone quality in the mouse digit amputation model using semi-automatic processing of microCT data

Hoffseth, K., Simkin, J., Busse, E., Stewart, K., Watt, J. D., Chapple, A. G., Hargrove, A., & Sammarco, M. C. (2020) · Bone · doi:10.1016/j.bone.2020.115776 · Cited by 10

Bone Strength/Bone Mass Discrepancy in Glucocorticoid‐Treated Adult Mice

Dubrovsky, A., Nyman, J. S., Uppuganti, S., Chmiel, K. J., Kimmel, D. B., & Lane, N. E. (2020) · JBMR Plus · doi:10.1002/jbm4.10443 · Cited by 10

A Bayesian path analysis to estimate causal effects of bazedoxifene acetate on incidence of vertebral fractures, either directly or through non-linear changes in bone mass density

Detilleux, J., Reginster, J., Chines, A. A., & Bruyère, O. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280212456655 · Cited by 10

Rationale, design and clinical performance of the mechanical response tissue analyser: a non-invasive technology for measurement of long bone bending stiffness

Miller, L. E., Ramp, W. K., Steele, C. R., Nickols‐Richardson, S. M., & Herbert, W. G. (2013) · Journal of Medical Engineering & Technology · doi:10.3109/03091902.2012.753128 · Cited by 10

Parathyroid hormone and its analogues--molecular mechanisms of action and efficacy in osteoporosis therapy.

Misiorowski, W. (2011) · PubMed · Cited by 10

Bone Overview

Mitton, D., Roux, C., & Laugier, P. (2010) · Springer eBooks · doi:10.1007/978-94-007-0017-8_1 · Cited by 10

Bone density testing to monitor osteoporosis therapy in clinical practice.

Muncie, H. L., & LeBlanc, L. L. (2010) · PubMed · Cited by 10

Evolution of atypical femur fractures and the association with bisphosphonates.

Takemoto, R. C., McLaurin, T. M., Tejwani, N. C., & Egol, K. A. (2014) · PubMed · Cited by 9

The 2024 Guidelines for Osteoporosis - Korean Society of Menopause

Lee, D. O., Hong, Y. H., Cho, M. K., Choi, Y. S., Chun, S., Chung, Y., Hong, S. H., Hwang, K. R., Kim, J., Kim, H., et al. (2024) · Journal of Menopausal Medicine · doi:10.6118/jmm.24000 · Cited by 11

Cortical bone plate properties assessment using inversion of axially transmitted low frequency ultrasonic guided waves

Chaboty, A. A., Nguyen, V., Haïat, G., & Bélanger, P. (2024) · The Journal of the Acoustical Society of America · doi:10.1121/10.0028173 · Cited by 9

The effects of teriparatide and bisphosphonates on new fractures in postmenopausal women with osteoporosis

Ouyang, Y., Chen, S., Wan, T., Zheng, G., & Sun, G. (2021) · Medicine · doi:10.1097/md.0000000000024839 · Cited by 9

Correlation between a Bone Resorption Marker and Structural Geometry of the Proximal Femur in Osteoporotic Women Treated with Raloxifene

Takada, J., Iba, K., Yoshizaki, T., & Yamashita, T. (2012) · Journal of orthopaedic surgery · doi:10.1177/230949901202000215 · Cited by 9

Inhibition of vascular endothelial growth factor in young adult mice causes low bone blood flow and bone strength with no effect on bone mass in trabecular regions

Lane, N. E., Nyman, J. S., Uppuganti, S., Chaudhari, A. J., Aguirre, J. I., Shidara, K., Liu, X. P., Yao, W., & Kimmel, D. B. (2019) · Bone Reports · doi:10.1016/j.bonr.2019.100210 · Cited by 9

Risedronate improves bone architecture and strength faster than alendronate in ovariectomized rats on a low-calcium diet

Yano, T., Yamada, M., Konda, T., Shiozaki, M., & Inoue, D. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0543-9 · Cited by 9

Monoclonal Gammopathy of Undetermined Significance: Why Identification of These Patients and Assessment of Their Skeletons Is Important

Berenson, J. R., & Yellin, O. (2009) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2009.n.061 · Cited by 9

DVO-Leitlinie 2006

Faßbender, W. J., & Stumpf, U. (2006) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-006-0092-x · Cited by 9

Biochemical markers of bone turnover and osteoporosis management

KRAENZLIN, M. E. (2007) · BoneKEy-Osteovision · doi:10.1138/20070266 · Cited by 9

Use of highly potent bisphosphonates in the treatment of osteoporosis

McClung, M. R. (2003) · Current Osteoporosis Reports · doi:10.1007/bf02686916 · Cited by 9

Quantifying the treatment effect explained by markers in the presence of measurement error

Sarkar, S., & Qu, Y. (2006) · Statistics in Medicine · doi:10.1002/sim.2695 · Cited by 9

Comparison of physiological and behavioral nutrition-related factors in people with and without adolescent idiopathic scoliosis, from cohort data at 8 to 20 years

Ng, P., Tucker, K. J., Zahir, S. F., Izatt, M. T., Straker, L. M., & Claus, A. P. (2024) · JBMR Plus · doi:10.1093/jbmrpl/ziad013 · Cited by 8

Association between Trunk Muscle Strength, Lumbar Spine Bone Mineral Density, Lumbar Scoliosis Angle, and Skeletal Muscle Volume and Locomotive Syndrome in Elderly Individuals: A Dual-Energy X-ray Absorptiometry Study

Takenaka, H., Ikemoto, T., Suzuki, J., Inoue, M., Arai, Y.-C. P., Ushida, T., Deie, M., & Kamiya, M. (2019) · Spine Surgery and Related Research · doi:10.22603/ssrr.2019-0083 · Cited by 8

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial

Piriyakhuntorn, P., Tantiworawit, A., Phimphilai, M., Srichairatanakool, S., Teeyasoontranon, W., Rattanathammethee, T., Hantrakool, S., Chai‐Adisaksopha, C., Rattarittamrong, E., Norasetthada, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1178761 · Cited by 8

How drugs decrease fracture risk: lessons from trials.

Cummings (2002) · PubMed · Cited by 31

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial

Chapurlat, R. D., Palermo, L., Ramsay, P., & Cummings, S. R. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1770-7 · Cited by 133

The role of parvovirus B19 in the pathogenesis of giant cell arteritis: A preliminary evaluation

Gabriel, S. E., Espy, M. J., Erdman, D. D., Björnsson, J., Smith, T. F. A., & Hunder, G. G. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6 · Cited by 156

Relationship Between Changes in Bone Mineral Density and Vertebral Fracture Risk Associated With Risedronate

Watts, N. B., Cooper, C. C., Lindsay, R., Eastell, R., Manhart, M. D., Barton, I. P., van Staa, T. P., & Adachi, J. D. (2004) · Journal of Clinical Densitometry · doi:10.1385/jcd:7:3:255 · Cited by 228

OP0113 Increases in bone mineral density explain the reduction in incidence of nonvertebral fractures seen with antiresorptive therapy in women with postmenopausal osteoporosis

Wasnich, R. D., Mc, H., Greenspan, S. L., Ross, P., & Miller, P. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2001.634